Skip to content

Study · Measured the body's own peptide · 1985

1 result

Substance P-, somatostatin-, vasoactive intestinal peptide- and cholecystokinin-like levels in the spinal cord of polyarthritic rats.

Chery-Croze S, Kocher L, Bernard C, Chayvialle JA

Brain research1 Jul 1985Cited by 17 (Europe PMC)

PMID2411344 (opens in a new tab)DOI10.1016/0006-8993(85)90642-0 (opens in a new tab)PepBankPUB-02411344
Publisher pagePubMedAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Natural levels measured1

These results measure the body's own peptide. Nobody was given the peptide. They are not evidence about taking it. They are left out of key results, evidence counts and charts.

  1. 01AnimalEndogenous levelAnimal study (in vivo)Other

    In polyarthritic rats, VIP-like levels in lumbar dorsal and ventral cord did not change compared with vehicle-treated controls.

    In plain wordsIn rats with arthritis, the body's own VIP in the lumbar spinal cord did not change compared with control rats.

    Peptide
    Vasoactive intestinal peptide (VIP, aviptadil)
    Outcome
    No significant changeVIP level in lumbar spinal cord
    Study

    ratn: not reported in source

    polyarthritic rats
    Comparator
    Vehicle-treated rats
    Outcome group
    Endogenous peptide levels · Nervous system and cognition

    Source sentences

    Summary
    Polyarthritis decreased substance P concentration in lumbar ventral cord and increased cholecystokinin level in lumbar dorsal cord, while the other two peptides did not show any change.
    1 context sentence
    Summary · context
    Substance P-, somatostatin-, vasoactive intestinal polypeptide- and cholecystokinin-like levels were measured in lumbar dorsal and ventral cord of polyarthritic rats and compared with those obtained in vehicle-treated rats taken as controls.

    This result measures the body's own Vasoactive intestinal peptide (VIP, aviptadil). Nobody was given the peptide. It is not evidence about taking it.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    12 Oct 2026, 12:58 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 12:41 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.